Cargando...

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas

The purpose of this study was to perform a meta-analysis examining the association of isocitrate dehydrogenase (IDH)1/2 mutations with overall survival (OS) and progression-free survival (PFS) in patients with glioblastomas. Medline, Cochrane, EMBASE, and Google Scholar were searched from inception...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Autores principales: Chen, Jun-Rui, Yao, Yu, Xu, Hong-Zhi, Qin, Zhi-Yong
Formato: Artigo
Lenguaje:Inglês
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782833/
https://ncbi.nlm.nih.gov/pubmed/26945349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002583
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!